MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 250 filers reported holding MEDIVATION INC in Q2 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,203,000 | -32.1% | 98,900 | +82.4% | 0.04% | -33.3% |
| Q2 2015 | $6,193,000 | +27.1% | 54,233 | +43.6% | 0.06% | +37.0% |
| Q1 2015 | $4,873,000 | -46.4% | 37,754 | -58.6% | 0.05% | -58.9% |
| Q4 2014 | $9,094,000 | +144.0% | 91,300 | +142.2% | 0.11% | +93.1% |
| Q3 2014 | $3,727,000 | +1022.6% | 37,700 | +776.3% | 0.06% | +728.6% |
| Q2 2014 | $332,000 | +53.0% | 4,302 | -2.3% | 0.01% | +133.3% |
| Q2 2013 | $217,000 | – | 4,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |